Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tyra Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q4 2021
- Shares held
- 36.1M
- +959.6K (+2.7%) vs. Q4 2021
- Total value
- $386.6M
- −$107.5M (−21.8%) vs. Q4 2021
- New holders
- 7
- 12 more added
- Sold out
- 6
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 459 | $5.00K | 0.00% | −2,706−85.5% | Reduced |
| Royal Bank of Canada | 725 | $8.00K | 0.00% | −1,766−70.9% | Reduced |
| Ameritas Investment Partners, Inc. | 940 | $10.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,126 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,243 | $13.0K | 0.00% | +280+29.1% | Added |
| Morgan Stanley | 1,571 | $16.0K | 0.00% | −34,177−95.6% | Reduced |
| UBS Group AG | 1,740 | $19.0K | 0.00% | −3,733−68.2% | Reduced |
| Amalgamated Bank | 1,771 | $19.0K | 0.00% | +1,771 | New |
| Amalgamated Financial Corp. | 1,771 | $19.0K | 0.00% | +1,771 | New |
| Barclays PLC | 1,915 | $20.0K | 0.00% | +1,915 | New |
| Wells Fargo & Company | 2,562 | $27.0K | 0.00% | −4,489−63.7% | Reduced |
| California State Teachers Retirement System | 5,064 | $54.0K | 0.00% | −1,601−24.0% | Reduced |
| American International Group, Inc. | 5,856 | $63.0K | 0.00% | −606−9.4% | Reduced |
| Deutsche Bank AG | 6,613 | $71.0K | 0.00% | −776−10.5% | Reduced |
| New York State Common Retirement Fund | 10,517 | $113.0K | 0.00% | +10,517 | New |
| Rhumbline Advisers | 11,726 | $125.0K | 0.00% | +11,726 | New |
| Nuveen Asset Management, LLC | 18,400 | $197.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 29,300 | $314.0K | 0.00% | −61,700−67.8% | Reduced |
| Bank of New York Mellon Corp | 30,620 | $328.0K | 0.00% | +10,045+48.8% | Added |
| Bank of America Corp | 64,126 | $686.0K | 0.00% | +58,401+1,020.1% | Added |
| Citadel Advisors LLC | 78,309 | $838.0K | 0.00% | −40.0% | Reduced |
| Charles Schwab Investment Management Inc | 80,456 | $861.0K | 0.00% | +1,109+1.4% | Added |
| D. E. Shaw & Co., Inc. | 83,438 | $893.0K | 0.00% | −44,425−34.7% | Reduced |
| Northern Trust Corp | 100,104 | $1.07M | 0.00% | −3,389−3.3% | Reduced |
| Sio Capital Management, LLC | 111,033 | $1.19M | 0.48% | +111,033 | New |
| Ensign Peak Advisors, Inc | 125,000 | $1.34M | 0.00% | 00.0% | Unchanged |
| State Street Corp | 203,680 | $2.18M | 0.00% | +72,670+55.5% | Added |
| Geode Capital Management, LLC | 210,549 | $2.25M | 0.00% | +4,168+2.0% | Added |
| JPMorgan Chase & Co | 228,482 | $2.44M | 0.00% | +73,903+47.8% | Added |
| Wellington Management Group LLP | 251,222 | $2.69M | 0.00% | −338,563−57.4% | Reduced |
| Logos Global Management LP | 252,726 | $2.70M | 0.35% | −220,668−46.6% | Reduced |
| Woodline Partners LP | 266,161 | $2.85M | 0.05% | +1,416+0.5% | Added |
| Perceptive Advisors LLC | 494,403 | $5.29M | 0.11% | −178,949−26.6% | Reduced |
| Vanguard Group Inc | 515,637 | $5.52M | 0.00% | −846−0.2% | Reduced |
| BlackRock Inc. | 583,236 | $6.24M | 0.00% | −5,330−0.9% | Reduced |
| Cormorant Asset Management, LP | 757,432 | $8.11M | 0.62% | −82,500−9.8% | Reduced |
| TCG Crossover Management, LLC | 896,418 | $9.59M | 3.85% | +45,968+5.4% | Added |
| Janus Henderson Group PLC | 909,192 | $9.72M | 0.00% | −257,289−22.1% | Reduced |
| Fairmount Funds Management LLC | 1,284,990 | $13.7M | 3.25% | +639,641+99.1% | Added |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $14.2M | 1.21% | +1,327,665 | New |
| BVF Inc | 2,472,327 | $26.5M | 1.06% | +598,995+32.0% | Added |
| Nextech Invest AG | 2,518,582 | $26.9M | 7.69% | 00.0% | Unchanged |
| FMR LLC | 4,090,085 | $43.8M | 0.00% | +621,254+17.9% | Added |
| Canaan Partners XI LLC | 4,409,991 | $47.2M | 19.65% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $69.0M | 3.55% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,236,454 | $77.4M | 1.69% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −1,250,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −109,523−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −17,999−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −300−100.0% | Sold out |